Free Online CME

Disease Management Clinical Decisions

Fibromyalgia

Print this Content

Release date: September 30, 2019
Expiration date: September 30, 2022

Estimated Time of Completion: 45 minutes

Description

Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Learning Objectives

After completing this case the reader should be able to:

  • List the most common clinical manifestations of fibromyalgia.
  • Describe the criteria for diagnosis fibromyalgia.
  • Accurately evaluate patients with fibromyalgia.
  • Individualize an appropriate treatment plan for patients with fibromyalgia.

Target Audience

Directed to primary care physicians including family practitioners and internists.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Co-Medical Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH

Faculty

Carmen E. Gota MD
Assistant Professor
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Fibromyalgia Clinic
Department of Rheumatologic and Immunologic Disease
Orthopaedic and Rheumatologic Institute,
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Anthony Fernandez, MD, PhD
  Novartis Consulting; Independent contractor (including contracted research); Teaching and Speaking
  Abbvie Pharmaceuticals Consulting; Teaching and Speaking
  Celgene Corporation Consulting
  Mallinckrodt Inc. Independent contractor (including contracted research);
Teaching and Speaking
  Pfizer, Inc. Independent contractor (including contracted research)
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial

The following faculty has indicated she has no relationship which, in the context of her presentation(s), could be perceived as a potential conflict of interest:

Carmen Gota, MD

 

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.